Cord Stähler
President at Hummingbird Diagnostics GmbH
Net worth: 3 M $ as of 31/03/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gregory Lucier | M | 59 | 5 years | |
Simon Campion | M | 53 | 2 years | |
Peer F. Staehler | M | 52 |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany.
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | 6 years |
Dorothea Wenzel | M | 55 | 2 years | |
Janet Vergis | F | 59 | 5 years | |
Richard Rosenzweig | M | 57 | 1 years | |
Karoly Nikolich | M | - |
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | - |
Jochen Kohlhaas | M | 61 |
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | - |
Clyde Hosein | M | 64 | 4 years | |
Thomas Miller | M | - |
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | 8 years |
Andrew Robinson | M | - | 2 years | |
Tom Miller | M | - |
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | - |
Scott Gazelle | M | - |
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | - |
Robert Johnson | M | 55 | 2 years | |
Ramon Güimil García | M | - |
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | - |
Glenn Coleman | M | 56 | 2 years | |
Bernd Seibel | M | 57 |
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | - |
Andreas Frank | M | 47 | 2 years | |
Richard Wagner | M | 56 | 2 years | |
Andrea Daley | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Groetelaars | M | 58 | 1 years | |
Michael J. Coleman | M | 80 | 3 years | |
Matthias Scheffler | M | - |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | - |
Lisa M. Yankie | F | 55 | 4 years | |
Chereé H. Johnson | F | 48 | 1 years | |
Jorge Gomez | M | 57 | 3 years | |
Barbara Bodem | F | 56 | - | |
Maureen J. MacInnis | F | 63 | 4 years | |
Arthur D. Kowaloff | M | 77 | 6 years | |
Markus Beier | M | 58 |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | - |
Don Casey | M | 64 | 4 years | |
Thomas Jetter | M | 67 | 3 years | |
Nicholas Alexos | M | 60 | 2 years | |
Michael C. Alfano | M | 76 | 5 years | |
Dave K. Beecken | M | 77 | 3 years | |
Francis J. Lunger | M | 78 | 5 years | |
Ramon Gueimil | M | - |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | - |
Heinz Blunier | M | - |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | - |
Walter Petersohn | M | 57 | 4 years | |
Markus Boehringer | M | 59 | 11 years | |
Ranjit Chadha | M | 54 | 2 years | |
William E. Newell | M | - | 15 years | |
Willem Appelo | M | 60 | - | |
Erania Brackett | F | 50 | 2 years | |
Michael Leggett | M | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 33 | 73.33% |
Germany | 12 | 26.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cord Stähler
- Personal Network